1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, May 2015 (p10)

Biopharmaceutical Analysis & Statistics, May 2015 (p10)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

271-300 of about 2 000 reports

Purchase Reports From Reputable Market Research Publishers

Glucagon Receptor Antagonists -Pipeline Insights, 2015

Glucagon Receptor Antagonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Glucagon Receptor Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Glucagon Receptor Antagonists. The main objective of this ...

  • Industries : Biopharmaceutical
Glucagon-Like Peptide (GLP) Agonists -Pipeline Insights, 2015

Glucagon-Like Peptide (GLP) Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Glucagon-Like Peptide (GLP) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Glucagon-Like Peptide (GLP) Agonists. The main ...

  • Industries : Biopharmaceutical
Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors -Pipeline Insights, 2015

Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors. ...

  • Industries : Biopharmaceutical
Anti-CD95 Antibody -Pipeline Insights, 2015

Anti-CD95 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD95 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD95 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Anti-CD80 Antibody -Pipeline Insights, 2015

Anti-CD80 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD80 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD80 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2015

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Tumor Necrosis Factor (TNF) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Tumor Necrosis Factor (TNF) Inhibitors. The main ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2015

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Tumor Necrosis Factor Alpha (TNF-a) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Tumor Necrosis Factor Alpha (TNF-a) Agonists. ...

  • Industries : Biopharmaceutical
Anti-CD33 Antibody -Pipeline Insights, 2015

Anti-CD33 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD33 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD33 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2015

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Lymphocyte Function-Associated ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
US Cancer Vaccine Market Outlook 2020

US Cancer Vaccine Market Outlook 2020

  • $ 1 200
  • Industry report
  • July 2015
  • by RNCOS

In the face of an alarmingly rising incidences of cancer and limited treatment options, physicians are being forced to look for precautionary vaccines beyond the conventional treatments. Hence, many research ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : World
Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

  • $ 1 100
  • Industry report
  • July 2015
  • by Igate Research

Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Healthcare
  • Countries : World
Anti-Infective Drug News 29 JUNE 2015

Anti-Infective Drug News 29 JUNE 2015

  • $ 1 114
  • Industry report
  • June 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Gardasil 9 To Keep Merck On Top Of HPV Market Industry Brief - ACIP Recommends Category B For Pfizer/GSK Meningitis B Vaccines Industry Brief - GSK Sells Legacy Meningitis Vaccines ...

  • Industries : Drug and Medication
  • Countries : China
Biosimilars Business Review Q2 2015

Biosimilars Business Review Q2 2015

  • $ 1 114
  • Industry report
  • June 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - FDA Will Continue To Face Criticism Until Interchangeability And Naming Issues Are Resolved Industry Brief - Pfenex Collaboration With Hospira Gains Early HSR Clearance Industry ...

  • Industries : Biopharmaceutical
  • Countries : Canada, Brazil
Anti-Infective Drug News 01 JUNE 2015

Anti-Infective Drug News 01 JUNE 2015

  • $ 1 114
  • Industry report
  • June 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Gilead Will Be Seeking Further Candidates Following HBV Vaccine Failure Industry Brief - Cempra Reports Phase III Data For Oral Solithromycin In CABP Industry Brief - Consilient ...

  • Industries : Drug and Medication, Biopharmaceutical
Anti-Infective Drug News 11 MAY 2015

Anti-Infective Drug News 11 MAY 2015

  • $ 1 114
  • Industry report
  • May 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - GSK's Shingles Vaccine To Erode Sales Of Merck's Zostavax Industry Brief - FDA Accepts NDA Filing For AuriPro Industry Brief - Single-Dose Dalvance Meets Primary/Secondary Endpoints ...

  • Industries : Drug and Medication, Biopharmaceutical
  • Countries : Europe, India, United States
Anti-Infective Drug News 27 APRIL 2015

Anti-Infective Drug News 27 APRIL 2015

  • $ 1 114
  • Industry report
  • April 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Sovaldi Pricing To Remain An Issue Despite Groundbreaking Programme Industry Brief - Actavis' Avycaz Available In US Industry Brief - Milestone Triggered As Evolva Completes Transfe ...

  • Industries : Drug and Medication, Biopharmaceutical
  • Countries : Japan
The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2016 Global Trade Perspective

The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2016 Global Trade Perspective

  • $ 795
  • Industry report
  • June 2015
  • by ICON Group

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for vaccines, antisera, and other blood fractions. With the globalization ...

  • Industries : Drug and Medication, Biopharmaceutical
  • Countries : World
Hycor Biomedical Inc. - Product Pipeline Analysis, 2015 Update

Hycor Biomedical Inc. - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • June 2015
  • by Global Data

Summary Hycor Biomedical Inc. (Hycor) is a medical device company that manufactures and markets in vitro diagnostics products. The company manufactures and markets systems and testing products for in vitro ...

  • Industries : Biopharmaceutical, Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic
  • Countries : United States
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars.

Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars.

  • $ 750
  • Industry report
  • May 2015
  • by Access China Management Consulting Ltd.

Synopsis Responding to strong desire of overseas and multinational pharmaceutical manufacturers and domestic pharmaceutical manufacturers to carry out research and development of biosimilar products, this ...

  • Industries : Biopharmaceutical
  • Countries : China
Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2015 Update

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Industry report
  • May 2015
  • by Global Data

Summary Exploit Technologies Pte Ltd (Exploit Technologies) is a technology transfer company. It provides technologies for license in various sectors industries such as Electronics, energy, Environment, ...

  • Industries : Diagnostics, Diagnostics, Pathology
  • Countries : Singapore
Physician Views: Will patient switching studies support biosimilar adoption?

Physician Views: Will patient switching studies support biosimilar adoption?

  • $ 695
  • Industry report
  • June 2015
  • by Firstword Pharma

Europe's first biosimilar monoclonal antibody – Celltrion and Hospira's biosimilar Remicade product Inflectra/Remsima – is approaching its second year anniversary, following approval in the second ...

  • Industries : Biopharmaceutical
  • Countries : Norway
Freedonia Focus on Enzymes: United States

Freedonia Focus on Enzymes: United States

  • $ 600
  • Industry report
  • May 2015
  • by Freedonia Focus

This report forecasts US enzyme demand in US dollars at the manufacturers’ level to 2019. Total demand is segmented by product in terms of carbohydrase, protease, polymerase, nuclease, and other enzymes. ...

  • Industries : Biopharmaceutical
Global Erythropoietin Market Outlook 2020

Global Erythropoietin Market Outlook 2020

  • $ 400
  • Industry report
  • July 2015
  • by RNCOS

Erythropoietin (EPO) treatment is an innovative technique to regulate red blood cells in a human body. The global erythropoietin industry has been languishing over the past few years and presenting very ...

  • Industries : Biopharmaceutical, Pathology
  • Countries : World
Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Drug and Medication, Diagnostics, Diagnostics
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2015
  • by Global Data

Summary Entest BioMedical, Inc. (Entest BioMedical) is a biomedical research company. The company develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human ...

  • Industries : Biopharmaceutical
XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2015
  • by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical ...

  • Industries : Biopharmaceutical
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2015
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. ...

  • Industries : Biopharmaceutical
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2015
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera), formerly Aestherx, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development abd commercialization of medical aesthetics ...

  • Industries : Biopharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.